v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Assets    
Cash $ 3,378,152 $ 2,401,831
Digital assets - current (Note 4) 9,021,927 3,416,256
Finance receivables 21,051 19,221
Marketable securities (Note 7) 27,050 17,860
Receivable from sale of Symbiont assets (Note 7) 200,000 200,000
Prepaid expenses and other assets 827,237 4,067,212
Income tax receivable 31,187 31,187
Current assets 13,506,604 10,153,567
Fixed assets, net (Note 5) 18,376,948 24,519,610
Intangible assets, net (Note 5) 5,478,958 0
Deposit on mining equipment (Note 6) 467,172 20,837
Notes receivable from Seastar Medical Holding Corporation (Note 7)   1,440,498
Long-term investments - equity securities (Note 7) 4,255 156,992
Investment in Seastar Medical Holding Corporation (Note 7) $ 200,790 $ 1,145,486
Investment, Issuer Affiliation [Extensible Enumeration] us-gaap:InvestmentAffiliatedIssuerMember us-gaap:InvestmentAffiliatedIssuerMember
Digital assets - long-term (Note 4) $ 5,000,000  
Operating lease - right of use assets (Note 9) 938,641 $ 189,009
Other assets 73,857 86,798
Long-term assets 30,540,621 27,559,230
Total assets 44,047,225 37,712,797
Liabilities and stockholders' equity    
Accounts payable and accrued expenses 989,563 2,064,909
Note payable - short-term (Note 8) 386,312 567,586
Due to related parties (Note 11) $ 15,944 $ 22,845
Other Liability, Current, Related Party [Extensible Enumeration] Related Party [Member] Related Party [Member]
Current portion of lease liability (Note 9) $ 170,967 $ 110,384
Total current liabilities 1,562,786 2,765,724
Note payable - long-term (Note 8) 6,365,345  
Lease liability - net of current portion (Note 9) 776,535 85,775
Long-term liabilities 7,141,880 85,775
Total liabilities 8,704,666 2,851,499
Stockholders' equity (Note 12)    
Preferred stock, par value $.001; 150,000,000 shares authorized; no shares issued and outstanding as of December 31, 2024 and December 31, 2023
Common stock, par value $.001; 350,000,000 shares authorized; 5,133,412 shares issued and outstanding as of December 31, 2024 and 2,492,964 as of December 31, 2023 4,602 2,493
Additional paid-in capital 102,685,470 95,145,376
Accumulated deficit (65,662,731) (58,961,461)
Total LM Funding America stockholders' equity 37,027,341 36,186,408
Non-controlling interest (1,684,782) (1,325,110)
Total stockholders' equity 35,342,559 34,861,298
Total liabilities and stockholders’ equity $ 44,047,225 $ 37,712,797

Source

HTML PDF
ZIP